In this report, we examined the rates of AFP testing performed and the proportions of elevated AFP levels in HCC patients using a United States population‐based database, and reported contemporary overall survival (OS) rates for three different racial groups. This evidence concerns the gene AFP and hepatocellular carcinoma.